Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12692]

Exercise during chemotherapy may help immune cells fight cancer – patients invited to join new trial

Exercise during chemotherapy may help immune cells fight cancer – patients invited to join new trial

Genomic abnormalities in T-follicular helper lymphoma and patient outcomes

Genomic abnormalities in T-follicular helper lymphoma and patient outcomes

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

Loss of Y chromosome leads to poor cancer outcomes

Loss of Y chromosome leads to poor cancer outcomes

ASCO 2025: Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced breast cancers

ASCO 2025: Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced breast...

ASCO 2025: Ramucirumab and pembrolizumab combo does not improve OS for previously treated advanced NSCLC

ASCO 2025: Ramucirumab and pembrolizumab combo does not improve OS for previously treated advanced NSCLC

ASCO 2025: Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

ASCO 2025: Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

ASCO 2025: Exercise programme may lower risk of recurrence and death for some colon cancer survivors

ASCO 2025: Exercise programme may lower risk of recurrence and death for some colon cancer survivors

ASCO 2025: Molecular assay may help identify people with NSCLC who could benefit from adjuvant chemotherapy

ASCO 2025: Molecular assay may help identify people with NSCLC who could benefit from adjuvant chemotherapy

ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer

ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients...

More from ecancer